Neuropathy as a potential complication of levodopa use in Parkinson's disease: a pharmacological and pharmacovigilance point of view.
Montastruc
Jean-Louis
JL
Danton
Anne Charlotte
AC
Durrieu
Genevieve
G
Lacroix
Isabelle
I
Olivier
Pascale
P
Sommet
Agnés
A
Senard
Jean-Michel
JM
D000978:Antiparkinson Agents / Q000009:adverse effects*; D016208:Databases, Factual / Q000706:statistics & numerical data; D006801:Humans; D007980:Levodopa / Q000009:adverse effects*; D010300:Parkinson Disease / Q000188:drug therapy; D011115:Polyneuropathies / Q000139:chemically induced*
D000978:Antiparkinson Agents; D007980:Levodopa